Eli Lilly (LLY) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Eli Lilly (LLY) closed at $804.99, marking a -0.39% move from the previous day.
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Some people make it a New Year's resolution to improve their finances by investing in stocks. It's a laudable goal, and to get started, it's crucial to pick stocks that have the tools to perform we...
Prediction: 3 Stocks That'll Be Worth More Than Berkshire Hathaway 5 Years From Now
It's not the biggest publicly traded company in the world right now. That honor still belongs to Apple with a market cap if just under $3.5 trillion.
Why Eli Lilly Stock Topped the Market Today
Eli Lilly (LLY 2.45%) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose by more than 2% on the day, thanks largely to news from a rival.
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds up well at these companies regardless of general economic conditions. B...
Eli Lilly (LLY) Rises Higher Than Market: Key Facts
Eli Lilly (LLY) closed at $753.98 in the latest trading session, marking a +1.57% move from the prior day.
This Best-of-Class Pharma Stock Could Soar 72% This Year According to Wall Street Insider
Eli Lilly (NYSE: LLY) doesn't really need much of an introduction.
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer's, Study Shows. What It Means for the Stocks.
Weight-loss medications have exploded in popularity but the health-benefits go beyond obesity.
Should You Buy the Dip in Eli Lilly Stock Right Now?
2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY -4.21%). At one point, share prices had gained as much as 65% on the year.
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
In the first half of 2024, it seemed Eli Lilly (LLY -4.21%) could do no wrong. Unfortunately, the good times didn't last very long.
Could Donald Trump Make Eli Lilly Stock a No-Brainer Buy in 2025?
Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's largest healthcare company, with a market cap that topped $860 billion at one ...
FDA Okays LLY's Omvoh for Second Inflammatory Bowel Disease Condition
FDA approves Lilly's Omvoh for Crohn's disease, expanding its use to the second major type of IBD condition.
Eli Lilly: Big 2025 Ahead, But Execution Risks Exist
Eli Lilly: Big 2025 Ahead, But Execution Risks Exist
Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here's why
Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 million below the low end of the company's prior guidance and includes $...
LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4
LLY's shares slip more than 6% as it cuts outlook for 2024 sales. Preliminary fourth-quarter revenues fall short of estimates.
Related Companies